Can-Fite BioPharma Ltd.

AGM Information • Jun 27, 2024

_________ false

��-���� ������� ��"�	2 381
CAN-FITE BIOPHARMA LTD
Corporation no: 512022153	14960
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	26/06/2024
	www.isa.gov.il			www.tase.co.il				Reference:	2024-02-065197	Time of broadcast: 15:56 15:56

---

The corporation scheduled the publication of the report to 26/06/2024 23:15Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

On June 26, 2024, Can-Fite BioPharma Ltd. (the �Company�) convened the Annual General Meeting of Shareholders (the �Annual General Meeting�), however, the Annual General Meeting was adjourned for one week to the same day, time and place due to lack of quorum. Accordingly, the Company�s Annual General Meeting will be reconvened on Wednesday, July 3, 2024 at 3:00p.m., Israel time at the Company�s offices located at 26 Ben Gurion Street, Ramat Gan, Israel.

ea020854001-6k_canfiteEDGAR1_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2024-02-059553
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 18/06/2024
Address: Bareket 10 , Petach-Tikva 47190   , Tel: 03-9241114 , 03-9213501 Fax: 03-9249378
E-mail address: motti@canfite.co.il   Company site: www.canfite.com
Previous names of reporting entity:
Name of the Signatory: FARBSTEIN MORDECHAI Position of Signatory in the reporting corporation: Chief Operating Officer & CFO Name of Employer Company:
Address: Maharal street 10 , Tel Aviv 6248110 Telephone: 052-8998671 Facsimile: E-mail: Motti@canfite.co.il 1